Quality & complianceOfficial
FDA classifies Fresenius DELFLEX 1.5% dextrose dialysis solution recall as Class II over sterility concerns
🇺🇸 FDA enforcement report · Wed 11 Nov 2026
Complaints of possible leaks from small perforations in the printed area of the primary bag prompted a nationwide US recall of DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose.
The US Food and Drug Administration has listed a Class II recall of DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose in its enforcement report dated 11 November 2026. The recalling firm is Fresenius Medical Care Renal Therapies Group, LLC, and the recall number is D-0169-2027.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Official source: FDA enforcement report ↗
Article written by VigiEye from the official source (FDA enforcement report). AI-assisted; check the source before acting.
More Quality & compliance
All →
BfArM publishes urgent field safety notice for Bentley InnoMed's BeFlow Iliac Covered Stent System
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM lists Siemens field safety notice for Dimension Urine Barbiturate Screen assay
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM publishes Medtronic MiniMed urgent field safety notice for MiniMed Go app
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM posts Merit Medical field safety notice for Philips BridgeT Balloon Prep Kit
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM posts Urgent Field Safety Notice for Biomet UK's Avantage Cup Gripper
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM publishes InterSystems field safety notice for TrakCare France software
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026